Pakke med 10 hætteglas4 på lagerSpar 18 %Tesamorelin 10 mg
Stabiliseret GHRH-analog
Tesamorelin GHRH analogue research peptide, Australian-shipped. Lab-verified ≥99% purity.
Kun til forskningsbrug. Denne forbindelse sælges strengt til in vitro-forskning og laboratorieformål og er ikke beregnet til humant indtag eller terapeutisk brug. Ved køb bekræfter du, at du er en kvalificeret forsker og accepterer vores fulde ansvarsfraskrivelse.
Kun 4 pakker tilbage
Stabiliseret analog af væksthormonfrigørende hormon undersøgt for virkninger på visceralt fedtvæv og IGF-1-akseaktivitet i forskningsmodeller.
Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.
Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mekanisme
Undersøgt for selektiv binding til GHRH-receptoren med forlænget halveringstid. Forskning forbundet med reducerede viscerale fedtmarkører og forhøjet IGF-1 i studiepopulationer.
HPLC-verificeret mod en renhedsspecifikation på ≥99 %. Uafhængigt testet af akkrediterede tredjepartslaboratorier.
Tesamorelin — ofte stillede spørgsmål
What is Tesamorelin?
Tesamorelin is a stabilised synthetic analogue of growth-hormone-releasing hormone (GHRH). It is studied in growth-hormone research and pre-clinical models of metabolic regulation and body composition.
Is Tesamorelin legal in Australia?
Tesamorelin is not approved as a therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Tesamorelin for research use only.
What is the difference between Tesamorelin and CJC-1295?
Both are GHRH-analogue research peptides. CJC-1295 has a longer half-life and a stronger ability to extend the duration of GH pulses; Tesamorelin's modifications produce a shorter-acting but well-characterised GHRH-mimicking profile. They are studied as parallel research tools for different aspects of GHRH-pathway signalling.
What is the typical Tesamorelin research dosage?
Published clinical research (in the US, for the approved indication) has used 2 mg daily subcutaneous Tesamorelin. Research-protocol dosing varies by model. Human therapeutic dosing is not established in Australia.
Guides relateret til Tesamorelin
Forskere udforsker også
UdvalgtPakke med 10 hætteglasSpar 25 %Retatrutide
Lyofiliseret pulver10 mg · 8 strengths
Tri-agonist GLP-1 / GIP / glukagon-forskningspeptid
I 1 stack
Pakke med 10 hætteglasSpar 22 %MOTS-c
Lyofiliseret pulver10 mg · 2 strengths
Mitokondrielt afledt metabolisk peptid
I 2 stacks
Pakke med 10 hætteglasSpar 17 %5-Amino-1MQ
Lyofiliseret pulver50 mg · 3 strengths
NNMT-hæmmer, forskningsforbindelse